Access essential information regarding global reimbursement issues, from Medtech Insight, In Vivo, Datamonitor Healthcare, Pink Sheet, Scrip, and others to understand the implications on your business.
35 Total results for product and free and sample content found
Administration under the medical benefit/Medicare Part B could mean easier reimbursement. The company outlined early plans for the launch of inclisiran after announcing it will buy The Medicines Company for $9.7bn.
Disease management and treatment programmes change, as research evolves and new discoveries are made. Your market access strategies must evolve too.
Join subject-matter experts from Datamonitor Healthcare as they use data and their industry experience to examine the challenges and opportunities brought about by recent global trends in market access. Learn how to navigate this complex terrain, as increasingly restrictive pricing and reimbursement policies are having an adverse effect on sales of launched and pipeline products across many global markets.
China proposes to merge its top drug regulator into new combined body, and creates a medical reimbursement agency in move viewed as sign of strengthening regulatory oversight.
A year after the NEST Coordinating Center was launched, the group has expanded its staff.
2017 saw developments that were beneficial to the Turkish medtech industry, like the continued progress of the billion-dollar City Hospitals project.
The pharmacy retail chain and drug distributor will buy the insurer for $69bn in a merger to build a new healthcare concept.
No Records Found
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: